跳至主要内容
临床试验/NCT06188832
NCT06188832已完成不适用

Efficacy of Dietary Fiber Supplementation (Soloways) in Patients With Specific Genetic Polymorphisms

S.LAB (SOLOWAYS)2 个研究点 分布在 1 个国家目标入组 108 人开始时间: 2022年3月2日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
108
试验地点
2
主要终点
Body-weight change in %

研究概览

简要总结

This randomized, double-blind, placebo-controlled trial assessed the impact of a dietary fiber supplement (glucomannan, inulin, and psyllium) on weight and metabolic parameters in individuals with obesity-related genetic polymorphisms (FTO, MC4R, LEP, LEPR). Participants were adults aged 18-65 with a BMI ≥ 25 and confirmed genetic predispositions. The study, involving 216 participants (108 per group), ran over 12 weeks with assessments at 0, 4, 8, and 12 weeks. Primary outcome was Body-weight change in %. The study aimed to clarify the role of fiber supplements in genetically predisposed obese individuals.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Confirmed presence of one or more specified gene polymorphisms (FTO, MC4R, LEP, LEPR).
  • Overweight or obese status (BMI ≥ 25).

排除标准

  • BMI < 25

结局指标

主要结局

Body-weight change in %

时间窗: 180 days

次要结局

  • LDL-C ratio(180 days)
  • Triglycerides ratio(180 days)
  • Body weight in kg(180 days)
  • Fat-free mass change in kg(180 days)
  • Visceral fat rating change from baseline(180 days)
  • Total cholesterol ratio(180 days)
  • hsCRP ratio(180 days)
  • Fasting plasma glucose mmol/l(180 days)
  • Side effects %(180 days)
  • body-weight reduction ≥5%(180 days)
  • body-weight reduc-tion ≥10%(180 days)
  • Fat mass change in %(180 days)
  • Systolic blood pressure in mmHg(180 days)
  • HDL-C ratio(180 days)
  • Body mass index change in %(180 days)
  • Diastolic blood pressure in mmHg(180 days)

研究者

发起方
S.LAB (SOLOWAYS)
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验